Drug data last refreshed 3d ago · AI intelligence enriched 3w ago
TECHNESCAN HIDA is a radiopharmaceutical diagnostic imaging agent containing Technetium Tc-99m bound to lidofenin for hepatobiliary scintigraphy. It is used to evaluate hepatic function, biliary tract patency, and gallbladder ejection fraction in patients with suspected biliary or hepatic disorders. The agent is administered as an intravenous injection and localizes in the liver, enabling real-time imaging of hepatobiliary physiology.
As a mature radiopharmaceutical approaching loss of exclusivity, the product likely operates with a smaller, maintenance-focused commercial team prioritizing operational efficiency and cost management.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on TECHNESCAN HIDA offers stability in a mature diagnostic market but limited growth trajectory or innovation exposure. Career advancement requires focus on operational efficiency, cost management, and maintaining physician relationships in a shrinking competitive space.
Worked on TECHNESCAN HIDA at Jubilant Therapeutics? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.